Neil Kumar is founder and CEO of Palo Alto, Calif.-based BridgeBio Pharma, a rare disease drug developer.

Ep190: Neil Kumar on Building a Rare Disease Drug Company

"The Long Run"

Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. 

Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

Science

"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

Share Ep190: Neil Kumar on Building a Rare Disease Drug Company

Sign up to save your podcasts

Ep190: Neil Kumar on Building a Rare Disease Drug Company

Ep190: Neil Kumar on Building a Rare Disease Drug Company

More shows like The Long Run with Luke Timmerman

The Knowledge Project

Conversations with Tyler

a16z Podcast

About Men Radio

POP | TECH | JAM

Strings and Things

The Readout Loud

Biotech 2050 Podcast

GoodFellows: Conversations from the Hoover Institution

Business Of Biotech

BioCentury This Week

Dwarkesh Podcast

Biotech Hangout

No Priors: Artificial Intelligence | Technology | Startups

Ground Truths

Complex Systems with Patrick McKenzie (patio11)

The Future of Everything

The Workup

Cheeky Pint